Repurposing dimethyloxalylglycine to inhibit glutamine metabolism
Tuesday, October 9, 2018 - 07:40
in Biology & Nature
A team of researchers from the U.K. and the U.S. has found that a drug used to study hypoxia can also be used to inhibit glutamine metabolism—a possible means for targeting cancer cells by cutting off their supply line. In their paper published in the journal Nature Chemical Biology, the group explains their study of the drug and its new possible use in targeting tumors. Barbara Nelson, Daniel Kremer and Costas Lyssiotis with the University of Michigan have written a News and Views piece on the work done by the team in the same journal issue.